Search results for "OTHER"

showing 10 items of 12132 documents

Doctors’ acceptance of recommendations for patients with the opportunity for pharmacotherapy improvement

2011

Abstract Objective To identify and quantify the influence of different variables on the implementation of pharmacotherapy optimisation measures in hospitalised patients. Method Descriptive transversal study. Period: 2000–2007. Environment: public university general hospital (25,000 patients admitted/year). The Programme implemented to improve pharmacotherapy quality and patient safety covers 30% of all patients. Using records from the Atefarm ® Farmis application, we analysed pharmacotherapy recommendations (PRs) made by pharmacists to doctors. The selected variables were the following: Risk of the medication for ADE (1-high, 0-low), ADE category, (0-indication, 1-effectiveness, 2-safety), …

medicine.medical_specialtyQuality managementbusiness.industryCross-sectional studyMEDLINELogistic regressionPatient safetyPharmacotherapySeverity of illnessEmergency medicinePhysical therapyMedicinebusinessCategorical variableFarmacia Hospitalaria (English Edition)
researchProduct

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience.

2021

Background: Pseudomyxoma peritonei (PMP) originating from appendiceal mucinous neoplasm is a rare peritoneal malignancy characterized by the progressive intraperitoneal accumulation of mucus leading to death if left untreated. In recent years, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) offered increased survival rates. This study aims to identify the clinical, pathological, and surgical features influencing safety and survival outcomes of patients undergoing CRS and HIPEC for PMP of appendiceal origin.Methods: A retrospective analysis of all patients undergoing CRS and HIPEC for PMP of appendiceal origin from January 2015 to May 2019 was cond…

medicine.medical_specialtyRD1-811HIPECbusiness.industrymedicine.diseaseSingle Centerhyperthermic intra peritoneal chemotherapyGastroenterologypseudomixoma peritoneiOxaliplatinRegimenperitonectomy procedureInternal medicinemedicinePeritoneal Cancer IndexAdenocarcinomaPseudomyxoma peritoneicytoreductive surgeryHyperthermic intraperitoneal chemotherapySurgerybusinessSurvival ratemedicine.drugOriginal ResearchFrontiers in surgery
researchProduct

A Review of Healthcare Failure Mode and Effects Analysis (HFMEA) in Radiotherapy

2016

This paper presents a review of risk analyses in radiotherapy (RT) processes carried out by using Healthcare Failure Mode Effect Analysis (HFMEA) methodology, a qualitative method that proactively identifies risks to patients and corrects medical errors before they occur. This literature review was performed to provide an overview of how to approach the development of HFMEA applications in modern RT procedures, comparing recently published research conducted to support proactive programs to identify risks. On the basis of the reviewed literature, the paper suggests HFMEA shortcomings that need to be addressed.

medicine.medical_specialtyRadiology Nuclear Medicine and ImagingEpidemiologyHealth Toxicology and MutagenesisMEDLINESensitivity and Specificity030218 nuclear medicine & medical imagingrisk estimate03 medical and health sciences0302 clinical medicineNeoplasmsHealth caremedicineHumansMedical physicsHealthcare Failure Mode and Effect Analysisrisk analysiRadiation InjuriesradiotherapySettore ING-IND/19 - Impianti NucleariRadiation medicalMedical Errorsbusiness.industryReproducibility of ResultsSurvival Rate030220 oncology & carcinogenesisbusinessFailure mode and effects analysis
researchProduct

Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis

2020

AbstractObjectiveThe randomized, controlled MAINRITSAN2 trial was designed to compare the capacity of an individually tailored therapy [randomization day 0 (D0)], with reinfusion only when CD19+ lymphocytes or ANCA had reappeared, or if the latter’s titre rose markedly, with that of five fixed-schedule 500-mg rituximab infusions [D0 + D14, then months (M) 6, 12 and 18] to maintain ANCA-associated vasculitis (AAV) remissions. Relapse rates did not differ at M28. This ancillary study was undertaken to evaluate the effect of omitting the D14 rituximab infusion on AAV relapse rates at M12.MethodsMAINRITSAN2 trial data were subjected to post-hoc analyses of M3, M6, M9 and M12 relapse-free surviv…

medicine.medical_specialtyRandomizationAntigens CD19Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGastroenterologyDisease-Free SurvivalDrug Administration ScheduleAntibodies Antineutrophil CytoplasmicMaintenance Chemotherapylaw.invention03 medical and health sciences0302 clinical medicineRheumatologyMaintenance therapyRandomized controlled triallawInternal medicinePost-hoc analysismedicineHumansPharmacology (medical)030212 general & internal medicineSurvival rate030203 arthritis & rheumatologybusiness.industrymedicine.diseaseAntirheumatic AgentsRituximabRituximabMicroscopic polyangiitisGranulomatosis with polyangiitisbusinessmedicine.drugRheumatology
researchProduct

Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data

2020

Objectives To estimate total direct health care costs associated to diagnosis and treatment of women with breast cancer in Italy, and to investigate their distribution by service type according to the disease pathway and patient characteristics. Methods Data on patients provided by population-based Cancer Registries are linked at individual level with data on health-care services and corresponding claims from administrative databases. A combination of cross-sectional approach and a threephase of care decomposition model with initial, continuing and final phases-of-care defined according to time occurred since diagnosis and disease outcome is adopted. Direct estimation of cancer-related cost…

medicine.medical_specialtyReal world dataTotal costEconomics Econometrics and Finance (miscellaneous)PopulationHealth care utilizationAdministrative dataBreast NeoplasmsSettore MED/42 - Igiene Generale E Applicata03 medical and health sciencesInsurance Claim Review0302 clinical medicineBreast cancerBreast cancerEnvironmental healthHealth careCost analysiCost analysisMedicineHumans030212 general & internal medicineRegistrieseducationRetrospective Studieseducation.field_of_studyHealth economicsbusiness.industry030503 health policy & servicesHealth PolicyPublic healthmedicine.diseaseHospitalizationCross-Sectional StudiesItalyCost driverCohortFemaleHealth Expenditures0305 other medical sciencebusinessDelivery of Health Care
researchProduct

Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the…

2022

Abstract Objectives To assess the toxicity patterns and effectiveness of doublet chemotherapy when administered at reduced doses of 20% (FOLFOX or FOLFIRI) in combination with anti-EGFR antibodies (cetuximab or panitumumab) in old, vulnerable patients with metastatic colorectal cancer (mCRC). Patients and methods We performed a retrospective observational study of RAS and BRAF wild-type, vulnerable patients aged ≥70 years with previously untreated mCRC. The primary endpoint was safety, and secondary endpoints were overall response rate (ORR), progression-free survival (PFS), and overall survival (OS). Results One hundred and eighteen patients were collected from 14 selected Italian centres.…

medicine.medical_specialtyReduced doseColorectal cancerLeucovorinCetuximabNeutropeniaGastroenterologyFOLFOXInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointHumansPanitumumabDoublet chemotherapyAnti-EGFRAgedCetuximabMetastatic colorectal cancerRectal Neoplasmsbusiness.industryPanitumumabAnti-EGFRs Doublet chemotherapy Metastatic colorectal cancer Reduced doses Vulnerable older patientsExanthemamedicine.diseaseRashVulnerable older patients.OncologyColonic NeoplasmsFOLFIRIFluorouracilGeriatrics and Gerontologymedicine.symptomColorectal Neoplasmsbusinessmedicine.drugJournal of Geriatric Oncology
researchProduct

Motor imagery and action observation following immobilization-induced hypoactivity: A narrative review.

2020

Abstract Background In sports, the risk of pathology or event that leads to an injury, a cessation of practice or even to an immobilization is high. The subsequent reduction of physical activity, or hypoactivity, induces neural and muscular changes that adversely affect motor skills and functional motor rehabilitation. Because the implementation of physical practice is difficult, if not impossible, during and immediately following injury or immobilization, complementary techniques have been proposed to minimize the deleterious impact of hypoactivity on neuromuscular function. Objective The current narrative review aimed to discuss the contributions of motor imagery and action observation, w…

medicine.medical_specialtyRehabilitationImagery Psychotherapymedicine.medical_treatmentRehabilitationKinesthetic learningContext (language use)Affect (psychology)Motor imageryPhysical medicine and rehabilitationMotor SkillsAction observationmedicineImaginationHumansLearningOrthopedics and Sports MedicineHypoactivityPsychologyKinesthesisMotor skillPhysical Therapy ModalitiesAnnals of physical and rehabilitation medicine
researchProduct

Accuracy of SCORTEN and ABCD‐10 to predict mortality and the influence of renal function in Stevens–Johnson syndrome/toxic epidermal necrolysis

2020

Epidermal necrolysis (EN) compromises a spectrum of life-threatening dermatoses (Stevens-Johnson Syndrome [SJS], overlap syndrome and toxic epidermal necrolysis [TEN]). Currently, no active therapeutic regimen with unequivocal benefit exists for SJS/TEN. SCORTEN is the widely-used prognostic scale specific for SJS/TEN. Nevertheless, a new prognostic scale, the ABCD-10, has been recently proposed. In this context, acute renal failure (ARF) seems to be an important comorbidity that could influence prognosis in SJS/TEN patients more than it is assumed by these two scales. Our objectives were to compare the accuracy of the SCORTEN and ABCD-10 scales in predicting the mortality in SJS/TEN, and t…

medicine.medical_specialtyRenal functionContext (language use)ComorbidityDermatologyEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicinemedicineHumansRetrospective Studiesbusiness.industryOverlap syndromeStevens johnsonGeneral MedicinePrognosismedicine.diseaseComorbidityToxic epidermal necrolysisstomatognathic diseasesSupportive psychotherapyStevens-Johnson Syndrome030220 oncology & carcinogenesisbusinessmedicine.drugThe Journal of Dermatology
researchProduct

Analysis of cardiac and pulmonary complication probabilities after radiation therapy for patients with early-stage breast cancer

2009

Objective. The purpose of this study was to evaluate the radiobiological implications of clinical use of respiratory-gated techniques for postoperative radiation therapy of early-stage left-sided breast cancer after breast-conserving surgery. Material and methods. Radiation therapy treatment plans of 80 patients with early-stage breast cancer (stage I–II), receiving whole breast irradiation after breast-conserving therapy, were analyzed. The control group consisting of 47 patients received standard radiation therapy, and the respiratory-gated group consisting of 33 patients received deep inspiration-gated radiation therapy. Normal tissue complication probabilities (NTCP) for cardiac mortali…

medicine.medical_specialtyRespiratory-Gated Imaging TechniquesHeart Diseasesearly-stage breast cancermedicine.medical_treatmentBreast NeoplasmsMastectomy SegmentalStatistics NonparametricCohort StudiesBreast cancerWhole Breast Irradiationnormal tissue complication probabilitymedicineHumansBreastStage (cooking)Radiation Injuriesrespiratory-gated radiotherapyPneumonitisNeoplasm StagingProbabilitybusiness.industryrespiratory-gated radiotherapy; early-stage breast cancer; breast-conserving therapy; normal tissue complication probabilityPatient SelectionRespirationPulmonary ComplicationRadiotherapy DosageGeneral Medicinemedicine.diseaseLatviaSurgeryRadiation therapyRadiation Pneumonitisbreast-conserving therapyFemaleRadiotherapy AdjuvantRadiotherapy ConformalComplicationbusinessTomography X-Ray ComputedMastectomyMedicina
researchProduct

Cardiac arrest in special circumstances

2021

Purpose of review European Resuscitation Council Guidelines for Cardiopulmonary Resuscitation prioritize treatments like chest compression and defibrillation, known to be highly effective for cardiac arrest from cardiac origin. This review highlights the need to modify this approach in special circumstances. Recent findings Potentially reversible causes of cardiac arrest are clustered into four Hs and four Ts (Hypoxia, Hypovolaemia, Hyperkalaemia/other electrolyte disorders, Hypothermia, Thrombosis, Tamponade, Tension pneumothorax, Toxic agents). Point-of-care ultrasound has its role in identification of the cause and targeting treatment. Time-critical interventions may even prevent cardiac…

medicine.medical_specialtyResuscitationDefibrillationbusiness.industrymedicine.medical_treatmentWater-Electrolyte ImbalanceHypothermiaHypothermiaReturn of spontaneous circulationCritical Care and Intensive Care Medicinemedicine.diseaseThrombosisCardiopulmonary ResuscitationHeart ArrestPulmonary embolismPregnancymedicineHumansFemaleTamponadeCardiopulmonary resuscitationmedicine.symptomIntensive care medicinebusinessOut-of-Hospital Cardiac ArrestCurrent Opinion in Critical Care
researchProduct